SANUWAVE Health (SNWV) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.78% |
| Dec 31, 2025 | 14.51% |
| Sep 30, 2025 | -42.53% |
| Jun 30, 2025 | 160.74% |
| Mar 31, 2025 | 338.83% |
| Sep 30, 2024 | 231.05% |
| Jun 30, 2024 | 189.69% |
| Mar 31, 2024 | 171.05% |
| Dec 31, 2023 | 47.12% |
| Sep 30, 2023 | 118.65% |
| Jun 30, 2023 | 156.93% |
| Mar 31, 2023 | 316.25% |
| Dec 31, 2022 | 99.55% |
| Sep 30, 2022 | 76.22% |
| Jun 30, 2022 | 98.80% |
| Mar 31, 2022 | 163.49% |
| Dec 31, 2021 | 18.15% |
| Mar 31, 2021 | 17.39% |
| Dec 31, 2020 | 15.13% |
| Sep 30, 2020 | 14.36% |
| Jun 30, 2020 | -47.05% |
| Mar 31, 2020 | -68.75% |
| Jun 30, 2019 | -53.66% |
| Mar 31, 2019 | -52.55% |
| Dec 31, 2018 | -13.17% |
| Sep 30, 2018 | -41.98% |
| Jun 30, 2018 | -56.05% |
| Mar 31, 2018 | -74.49% |
| Dec 31, 2017 | -39.90% |
| Sep 30, 2017 | -32.52% |
| Jun 30, 2017 | -39.89% |
| Mar 31, 2017 | -54.92% |
| Dec 31, 2016 | 0.15% |
| Dec 31, 2015 | -0.09% |